RENAU.UNSP.ARD 1/5 EO-20 (56S0) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.047x

Based on the latest financial reports, RENAU.UNSP.ARD 1/5 EO-20 (56S0) has a cash flow conversion efficiency ratio of 0.047x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€193.30 Million ≈ $225.99 Million USD) by net assets (€4.14 Billion ≈ $4.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RENAU.UNSP.ARD 1/5 EO-20 (56S0) balance sheet quality index to measure how much of total assets are equity-financed.

RENAU.UNSP.ARD 1/5 EO-20 - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how RENAU.UNSP.ARD 1/5 EO-20's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check RENAU.UNSP.ARD 1/5 EO-20 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

RENAU.UNSP.ARD 1/5 EO-20 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RENAU.UNSP.ARD 1/5 EO-20 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
PTT Exploration and Production Public Company Limited
F:NVAL
0.085x
Korea Electric Power Corp
KO:015760
0.071x
CSG N.V.
AS:CSG
-0.331x
Bank of Beijing Co Ltd
SHG:601169
-0.375x
Jde Peets Nv
AS:JDEP
0.066x
Akamai Technologies Inc
NASDAQ:AKAM
0.074x
Ball Corporation
NYSE:BALL
-0.138x
HAL Trust
AS:HAL
0.088x

Annual Cash Flow Conversion Efficiency for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)

The table below shows the annual cash flow conversion efficiency of RENAU.UNSP.ARD 1/5 EO-20 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see 56S0 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €4.13 Billion
≈ $4.82 Billion
€692.20 Million
≈ $809.25 Million
0.168x -17.18%
2024-12-31 €4.02 Billion
≈ $4.70 Billion
€815.10 Million
≈ $952.94 Million
0.203x -27.43%
2023-12-31 €2.67 Billion
≈ $3.13 Billion
€746.40 Million
≈ $872.62 Million
0.279x +14.62%
2022-12-31 €2.51 Billion
≈ $2.94 Billion
€612.30 Million
≈ $715.84 Million
0.244x --

About RENAU.UNSP.ARD 1/5 EO-20

F:56S0 Germany Medical Instruments & Supplies
Market Cap
$19.33 Billion
€16.54 Billion EUR
Market Cap Rank
#1606 Global
#347 in Germany
Share Price
€17.00
Change (1 day)
+0.59%
52-Week Range
€14.60 - €21.80
All Time High
€35.31
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more